A free, evidence-based educational programme from PatientsCann UK covering UK medical cannabis law, patient rights, and practical guidance for patients, carers, healthcare professionals, employers, police, and educators.
Yes. Since November 2018, cannabis-based products for medicinal use (CBPMs) became Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001. Any GMC-registered specialist doctor can prescribe them. Patients hold full legal authority to possess and use their medicine.
Yes, with conditions. The statutory medical defence under Section 5A(3) Road Traffic Act 1988 protects prescribed patients from the blood THC limit offence — but only if the medicine was taken as prescribed and driving was not impaired. The defence does not cover Section 4 impaired driving. Always carry medicine in original pharmacy packaging with the dispensing label.
There is no general legal duty to proactively disclose a cannabis prescription to your employer. Your health information is special category data under UK GDPR Article 9. Some safety-critical roles carry specific obligations — seek specialist employment law advice before disclosing.
No. Lawful possession of prescribed medicine is not a statutory ground for eviction under the Housing Act 1988. A CBPM prescription removes all criminal liability for possession. Pursuing enforcement on this basis may also breach the Equality Act 2010.
A UK prescription provides no legal protection outside the UK. Many countries criminalise all cannabis regardless of prescription. International travel requires advance planning — often 2 to 3 months — and may require import and export licences. For many destinations, switching to an alternative medicine is the safest option.
The Home Office confirms that the dispensing label on original pharmacy packaging plus photo ID is legally sufficient proof of a lawful CBPM prescription. Commercial third-party cannabis cards are not endorsed by the Home Office and have no legal standing.
No. Home Office FOI 2023/05814 confirmed that vaping devices including CBPM vaporisers fall outside smoke-free legislation, because smoke-free laws apply only to smoking by combustion. A venue no-vaping policy is a private contractual rule, not a statutory prohibition.
You may be eligible if you are 18 or over, have a diagnosed condition, and have tried at least two prior treatments without adequate response. A GMC-registered specialist makes the final decision. Clinics can be contacted directly without a GP referral.
There is no fixed approved list. A GMC-registered specialist can prescribe a CBPM for any condition where clinical evidence supports it. Commonly treated conditions include chronic pain, PTSD, anxiety, MS-related spasticity, chemotherapy-induced nausea, and refractory epilepsy.
If your underlying condition qualifies as a disability, your employer has a legal duty to make reasonable adjustments, which can include modifying drug testing policies. Housing providers, venues, and services also have Equality Act obligations to disabled patients.
An employer who immediately dismisses a prescribed patient without occupational health involvement risks unfair dismissal and Equality Act 2010 violations. The correct process is occupational health assessment, consideration of reasonable adjustments, and a fair procedure before any disciplinary action.
Rarely. NICE guidance has approved only a small number of specific products for NHS prescribing. The vast majority of medical cannabis is prescribed privately. NHS GPs cannot currently initiate CBPM prescriptions but may participate in shared care after specialist initiation.
Section 5A(3) Road Traffic Act 1988 provides a defence against the blood THC limit offence if the medicine was lawfully prescribed, taken as directed, and driving was not impaired. It does not cover Section 4 impaired driving and applies at the blood test stage, not the roadside swab stage.
A CBPM is a cannabis-based product for medicinal use — a pharmaceutical-grade, GMP-manufactured medicine. Since November 2018, any GMC-registered specialist doctor including those in private practice can initiate a prescription. Before prescribing, the patient must have tried at least two prior treatments.
Under Section 10 of the Care Act 2014, every carer providing regular and substantial unpaid care has a right to a Carer's Assessment from their local authority. Carer's Allowance is available for those providing 35 or more hours of care per week. Local authorities have a duty to promote carer wellbeing.
THC is the psychoactive cannabinoid responsible for pain relief, anti-nausea effects, appetite stimulation, and muscle relaxation. CBD is non-psychoactive and has anti-inflammatory, anxiolytic, and anticonvulsant properties. Most prescribed cannabis medicines contain varying ratios of both cannabinoids.
A venue can enforce a private no-vaping policy contractually. However, if you have a qualifying disability under the Equality Act 2010 the venue has a duty to consider reasonable adjustments. Inconsistently allowing e-cigarettes while banning a medical vaporiser used by a disabled patient creates a discrimination risk.
Stay calm. You cannot refuse a roadside oral drug swab — refusal is a criminal offence. Comply, then present your dispensing label and photo ID. Declare any pre-existing conditions before any Field Impairment Test element begins. The statutory medical defence applies at the blood test stage.
The endocannabinoid system is a regulatory network in the human body discovered in the early 1990s. It is involved in pain, inflammation, sleep, mood, appetite, and immune function. Cannabis medicines work by interacting with CB1 and CB2 receptors within this system.
GMP stands for Good Manufacturing Practice, the pharmaceutical quality standard applied to all prescribed CBPMs. It ensures consistent cannabinoid content, testing for pesticides and contaminants, accurate dosage, and batch traceability — unlike unregulated street cannabis.
The Grow Access Project provides subsidised clinic fees and discounted medications for patients on means-tested benefits including Universal Credit, PIP, ESA, and Housing Benefit, as well as veterans, Blue Light Card holders, and UK university students aged 18 and over. Mamedica offers a lifetime access scheme for a one-time fee.
Yes. DfE statutory guidance from 2017 requires schools to support pupils with any lawfully prescribed medicine including CBPMs. A healthcare plan should be agreed with parents. A student with a valid prescription confirmed by the dispensing label is not a safeguarding concern by virtue of having the prescription.
Yes. Health data including prescription details is special category data under UK GDPR Article 9 with the strongest data protection in law. Employers cannot demand full prescription details without a specific lawful basis. Drug test results are also special category data with strict sharing restrictions.
PatientsCann UK is the UK's leading patient-led medical cannabis organisation — a non-profit Community Interest Company run by patients, for patients. It provides free legal guidance, educational resources, and community support for the estimated 250,000 or more UK patients with a medical cannabis prescription. Website: patientscann.org.uk.
PatientsCann UK is the UK\'s leading patient-led medical cannabis organisation. Free resources at patientscann.org.uk. Educational purposes only — always consult a qualified healthcare professional and solicitor for personal advice.